There are at least two approaches to antileprosy vaccines : One is the use of Mycobacterium leprae derived from M. leprae-infected armadillos (1) and the other is the use of mycobacteria other than M. leprae, which share the antigenic determinants with M. leprae such as M. nonchromogenicum (2), M. vaccae (2), M. simiae (3), M. tuberculosis H37Ra (3), and M, bovis BCG (3). Shepard et al. (3) reported that BCG could sensitize mice against M. leprae, on the basis of development of the delayed type hypersensitivity reactions as measured footpad swelling, and that the sensitizing efficacy of BCG was much more satisfactory than those of the other mycobacteria mentioned above. It was of interest to consider another observation (3) that BCG and M. leprae could provide the enhanced host with resistance against subsequent M. leprae infection. Shepard et al. (4) reported that a vaccine of viable BCG combined with heat-killed M. leprae exhibited a superior protective effect over M. leprae or BCG alone against M. leprae infection, particularly in low doses. The efficacy of the combined vaccine of BCG and killed M. leprae in clinical applications was reported by Convit et al. (5), who observed that the Mitsuda reactions converted to positive in patients administered a mixture of the two mycobacteria, but not of either alone. We gave mice a combined vaccine of gamma-irradiated M. leprae and BCG and the results are reported herein.
Materials and Methods
Mice : Five-week-old male CBA/JN mice purchased from Charles River Co., Kanagawa, were used.
M. leprae infection : Suspension of nude mouse-derived M. leparae Kurume-Naha was obtained from Dr. K. Kohsaka, Research Institute of Microbial Diseases, Osaka University, Osaka. Mice were given 1*104 M. leprae in 0.03ml of saline into left hind footpad.
Vaccination : M. leprae was purified from gamma-irradiated armadillo liver infected with M. leprae (donated by Sasakawa Memorial Health Foundation, Tokyo) by aqueous two phase separation (6) . Lyophilized BCG (Japanese strain) was purchased from Nippon BCG Laboratory, Tokyo. One-twentieth ml of a mixture in saline of the equal amount of 1*109/ml of purified M, leprae and 4ml/ml of BCG was given subcutaneously into the lower dorsum of mice. The vaccination was initiated 2 weeks after infection and was repeated once biweekly (N was the number of M, leprae detected in a 0.18*R mm-square).
Results
As shown in Fig. 1 , the number of challenged M, leprae recovered from the footpad of Fig. 1 Effect of a combined vaccine of gamma-irradiated M. leprae and viable BCG on the growth of M. leprae given into the hind footpad of mice at 118 days (A) and 187 days (B) after challenge.
Experimental conditions are described in "Materials and Methods". Open circles indicate the data for individual mice and the bars represent the mean±SE for each experimental group. mice vaccinated with a mixuture of M. leprae and BCG was considerably higher at 118 days (A), but slightly less at 187 days after infection (B) compared to findings in non-vaccinated controls. The thickness of the left hind footpad (M. leprae infected site) and the right hind footpad (M. leprae uninfected site) of the animals was as follows : 118 days after infection ; non-vaccinated control mice, 2.76 ±0.02mm (left) (mean ± SE, n =5) and 2.76 ±0.02mm (right), vaccinated mice, 2.82±0.06mm (left) and 2.79±0.02mm (right), and 187 days after infection ; non-vaccinated control mice, 2.89 ±0.03mm (left, n10) and 2.89 ± 0.04mm (right), vaccinated mice, 2.91±0.02mm (left) and 2.89±0.03mm (right). Thus, there was no footpad swelling at the M. leprae infected site, indicating that the inflammatory reactions by M. leprae infection itself or by the delayed type hypersensitivity specific for M, leprae were not produced in the infection sites, of both the non-vaccinated control and M. leprae-BCG vaccinated mice.
Discussion
We examined a combined vaccine of gamma-irradiated M. leprae and live BCG for therapeutic effects on M. leprae infection in mice. As indicated in Fig. 1 , multiple vaccinations once biweekly from 2 weeks after infection up to the end of the experiment (187-days) caused no significant inhibition of the growth of M, leprae at the infection site. Shepard et al. (3, 4) reported that the vaccinations of heat-killed M. leprae in combination with BCG or either alone 4 weeks before challenge infection with M. leprae showed a marked protection against the infection and that the combined vaccine of M. leprae and BCG exhibited the highest protection, particularly at low doses. The discrepancy of these findings is attributed to differences in the experimental designs, that is, we studied the therapeutic effect, whereas they studied the protective effect of the combined vaccine against M. leprae infection. Differences in the BCG-strains used may also account for these different findings. totally dependent upon the ability of the host immune system to respond to its antigens, in a local as well as systemic manner.
Summary
Gamma-irradiated M. leprae in combination with BCG given once biweekly to mice from 2 weeks for up to 187 days after infection with M. leprae caused no significant growth inhibition of M. leprae, at the site of the infection.
